1. TAM family kinases as therapeutic targets at the interface of cancer and immunity
   Deborah DeRyckere et al, 2023, Nature Reviews Clinical Oncology CrossRef
2. Development of Gilteritinib-Based Chimeric Small Molecules that Potently Induce Degradation of FLT3-ITD Protein
   Nobumichi Ohoka et al, 2022, ACS Medicinal Chemistry Letters CrossRef
3. A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
   Ahmad Nasimian et al, 2023, International Journal of Molecular Sciences CrossRef
4. AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies
   Niels Vandewalle et al, 2024, Experimental Hematology & Oncology CrossRef
5. Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure
   Debora Capelli et al, 2022, Cancers CrossRef